- Home
- / Portola Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Portola Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$116.6 M
FY, 2019
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 40.1M | 116.6M | |||||
| Cost of goods sold | 18.1M | 44.4M | |||||
| Gross profit | 22.0M | 72.3M | |||||
| Gross profit margin, % | 54.9% | 62.0% | |||||
| General and administrative expense | 15.4M | 23.6M | 38.9M | 58.2M | 91.1M | 151.2M | 218.9M |
| Operating expense total | 94.8M | 147.2M | 239.2M | 305.1M | 294.8M | 367.4M | 343.5M |
| EBIT | (84.2M) | (137.6M) | (227.2M) | (269.6M) | (272.7M) | (345.3M) | (271.3M) |
| EBIT margin, % | -860.5% | -232.6% | |||||
| Interest expense | 441.0K | 305.0K | 1.5M | 1.3M | 13.5M | 9.7M | |
| Pre tax profit | (226.9M) | (268.1M) | (285.6M) | ||||
| Income tax expense | (365.0K) | ||||||
| Net Income | (83.4M) | (137.1M) | (226.5M) | (269.0M) | (286.1M) | (350.2M) | (290.7M) |